lux-lung 7: phase 2b trial of first-line afatinib versus gefitinib for egfr mutation-positive nsclc
Published 8 years ago • 293 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
1:21
lux-lung 7: phase 2b trial of afatinib versus gefitinib for egfr-mutated lung cancer in first-line
-
1:31
lux-lung 7: phase 2b trial of afatinib versus gefitinib for egfr-mutated adenocarcinoma of the lung
-
2:15
phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma
-
1:35
afatinib for advanced egfrm-positive nsclc
-
3:07
efficacy and safety of afatinib vs erlotinib and gefitinib in egfr nsclc
-
17:27
how, when, and where to utilize erlotinib, afatinib, and gefitinib in egfr positive nsclc
-
8:03
7 best vegetables for healthy lungs (detox and cleanse)
-
7:43
lung expansion therapy
-
4:03
landscape of targeted therapies in lung cancer
-
0:51
dr. tianhong (tina) li reviews the lux-lung 3 trial afatinib data
-
1:30
dr. langer on afatinib for advanced non-small cell lung cancer
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
3:38
overview of the world of egfr mutant lung cancers
-
4:09
frontline afatinib in egfr-mutant nsclc
-
5:59
targeted therapy in consolidation setting for lung cancer
-
5:13
gracecast-115_lung-cancer_asco 2012 lc highlights: dr. neal on lux-lung 3 trial for advanced nsclc
-
![[lung] afatinib vs cisplatin chemo for egfr lung cancer: survival data from lux-lung trials](https://i.ytimg.com/vi/LY68J1b1Ts0/mqdefault.jpg)
8:03
[lung] afatinib vs cisplatin chemo for egfr lung cancer: survival data from lux-lung trials
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
10:37
lux-lung 7 head-to-head clinical trial
-
5:47
egfr tkis for upfront treatment of nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc